National assessment of anti-epileptic drug exposures among pre-teens and adolescents, 2000-2020.

Toce, Michael S; Hudgins, Joel D; Yuskaitis, Christopher J; Monuteaux, Michael C; Bourgeois, Florence T

Toce, Michael S; Hudgins, Joel D; Yuskaitis, Christopher J; Monuteaux, Michael C; Bourgeois, Florence T.

Afiliación

Toce MS; Division of Emergency Medicine, Boston Children's Hospital, Boston, MA, USA.
Hudgins JD; Department of Pediatrics, Harvard Medical School, Boston, MA, USA.
Yuskaitis CJ; Harvard Medical Toxicology Program, Boston Children's Hospital, Boston, MA, USA.
Monuteaux MC; Division of Emergency Medicine, Boston Children's Hospital, Boston, MA, USA.
Bourgeois FT; Department of Pediatrics, Harvard Medical School, Boston, MA, USA.

Clin Toxicol (Phila) ; 60(6): 681-687, 2022 06.

Article en En | MEDLINE | ID: mdl-35025708

Asunto(s)

Anticonvulsivantes; Epilepsia; Adolescente; Anticonvulsivantes/uso terapéutico; Niño; Estudios Transversales; Epilepsia/tratamiento farmacológico; Epilepsia/epidemiología; Humanos; Lamotrigina; Estudios Retrospectivos

Palabras clave

NPDS; Pediatrics; adolescent; anti-epileptic drugs; poisoning

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Epilepsia / Anticonvulsivantes Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Adolescent / Child / Humans Idioma: En Revista: Clin Toxicol (Phila) Asunto de la revista: TOXICOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google